NYSE:INFU InfuSystem (INFU) Stock Price, News & Analysis $6.16 -0.01 (-0.16%) As of 07/3/2025 03:30 PM Eastern Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock About InfuSystem Stock (NYSE:INFU) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get InfuSystem alerts:Sign Up Key Stats Today's Range$6.13▼$6.3150-Day Range$4.70▼$6.4652-Week Range$4.61▼$9.97Volume45,677 shsAverage Volume115,480 shsMarket Capitalization$129.46 millionP/E Ratio102.68Dividend YieldN/APrice Target$13.00Consensus RatingStrong Buy Company Overview InfuSystem Holdings, Inc., through its subsidiaries, provides infusion pumps, and related products and services in the United States and Canada. The company operates in two segments, Patient Services and Device Solutions. It supplies electronic ambulatory infusion pumps and associated disposable supply kits to oncology, infusion, and hospital outpatient chemotherapy clinics for the treatment of various cancers, including colorectal cancer, pain management, and other disease states. The company also sells, rents, and leases new and pre-owned pole-mounted and ambulatory infusion pumps, and other durable medical equipment; sells treatment-related consumables; and provides biomedical recertification, maintenance, and repair services for oncology practices, as well as other healthcare site settings comprising hospitals, home care and home infusion providers, skilled nursing and acute care facilities, pain centers, and others. In addition, it offers local and field-based customer support, as well as operates pump service and repair centers. The company was incorporated in 2005 and is headquartered in Rochester Hills, Michigan. Read More InfuSystem Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks39th Percentile Overall ScoreINFU MarketRank™: InfuSystem scored higher than 39% of companies evaluated by MarketBeat, and ranked 671st out of 929 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion2.0 / 5Analyst RatingStrong Buy Amount of Analyst CoverageInfuSystem has only been the subject of 1 research reports in the past 90 days.Read more about InfuSystem's stock forecast and price target. Earnings and Valuation1.9 / 5Proj. Earnings Growth106.67% Earnings GrowthEarnings for InfuSystem are expected to grow by 106.67% in the coming year, from $0.15 to $0.31 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of InfuSystem is 102.68, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.61.Price to Earnings Ratio vs. SectorThe P/E ratio of InfuSystem is 102.68, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 27.43.Price to Book Value per Share RatioInfuSystem has a P/B Ratio of 2.49. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted3.20% of the float of InfuSystem has been sold short.Short Interest Ratio / Days to CoverInfuSystem has a short interest ratio ("days to cover") of 4.1.Change versus previous monthShort interest in InfuSystem has recently increased by 19.29%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldInfuSystem does not currently pay a dividend.Dividend GrowthInfuSystem does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted3.20% of the float of InfuSystem has been sold short.Short Interest Ratio / Days to CoverInfuSystem has a short interest ratio ("days to cover") of 4.1.Change versus previous monthShort interest in InfuSystem has recently increased by 19.29%, indicating that investor sentiment is decreasing significantly. News and Social Media0.0 / 5News SentimentN/A MarketBeat FollowsOnly 1 people have added InfuSystem to their MarketBeat watchlist in the last 30 days. This is a decrease of -50% compared to the previous 30 days. Company Ownership4.2 / 5Insider TradingAcquiring Shares Insider Buying vs. Insider SellingIn the past three months, InfuSystem insiders have bought more of their company's stock than they have sold. Specifically, they have bought $46,629.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders11.40% of the stock of InfuSystem is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions71.13% of the stock of InfuSystem is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about InfuSystem's insider trading history. Receive INFU Stock News and Ratings via Email Sign-up to receive the latest news and ratings for InfuSystem and its competitors with MarketBeat's FREE daily newsletter. Email Address INFU Stock News HeadlinesInfuSystem: Investments Are Starting To Pay OffJune 22, 2025 | seekingalpha.comInfuSystem Holdings, Inc. (INFU) Q1 2025 Earnings Call TranscriptMay 10, 2025 | seekingalpha.comBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly positioned to fill it…July 5 at 2:00 AM | Crypto 101 Media (Ad)Earnings call transcript: InfuSystem Q1 2025 sees stock surge despite EPS missMay 10, 2025 | uk.investing.comInfuSystem Holdings, Inc. (AMEX:INFU) Q1 2025 Earnings Call TranscriptMay 10, 2025 | insidermonkey.comInfuSystem Reports First Quarter 2025 Financial ResultsMay 8, 2025 | finance.yahoo.comInfuSystem to Report First Quarter 2025 Financial Results on May 8, 2025May 1, 2025 | businesswire.comInfuSystem CEO stepping down May 19, COO Carrie Lachance succeedsApril 2, 2025 | markets.businessinsider.comSee More Headlines INFU Stock Analysis - Frequently Asked Questions How have INFU shares performed this year? InfuSystem's stock was trading at $8.45 at the beginning of 2025. Since then, INFU stock has decreased by 27.1% and is now trading at $6.16. How were InfuSystem's earnings last quarter? InfuSystem Holdings, Inc. (NYSE:INFU) issued its earnings results on Thursday, November, 7th. The company reported $0.08 earnings per share for the quarter, hitting the consensus estimate of $0.08. The company earned $35.32 million during the quarter, compared to the consensus estimate of $35.50 million. InfuSystem had a trailing twelve-month return on equity of 2.78% and a net margin of 1.12%. How do I buy shares of InfuSystem? Shares of INFU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of InfuSystem own? Based on aggregate information from My MarketBeat watchlists, some other companies that InfuSystem investors own include Advanced Micro Devices (AMD), Tesla (TSLA), NVIDIA (NVDA), Meta Platforms (META), Home Depot (HD), JPMorgan Chase & Co. (JPM) and Netflix (NFLX). Company Calendar Last Earnings11/07/2024Today7/05/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNYSE:INFU Previous SymbolNYSE:INFU CIK1337013 Webwww.infusystem.com Phone(248) 291-1210Fax800-455-4338Employees410Year FoundedN/APrice Target and Rating Average Stock Price Target$13.00 High Stock Price Target$13.00 Low Stock Price Target$13.00 Potential Upside/Downside+111.0%Consensus RatingStrong Buy Rating Score (0-4)4.00 Research Coverage2 Analysts Profitability EPS (Trailing Twelve Months)$0.14 Trailing P/E Ratio102.68 Forward P/E Ratio41.07 P/E GrowthN/ANet Income$870 thousand Net Margins1.12% Pretax Margin2.65% Return on Equity2.78% Return on Assets1.41% Debt Debt-to-Equity Ratio0.50 Current Ratio1.98 Quick Ratio1.59 Sales & Book Value Annual Sales$137.58 million Price / Sales0.94 Cash Flow$0.48 per share Price / Cash Flow12.79 Book Value$2.47 per share Price / Book2.49Miscellaneous Outstanding Shares21,016,000Free Float19,095,000Market Cap$129.46 million OptionableOptionable Beta1.81 Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report This page (NYSE:INFU) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | SponsoredTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InfuSystem Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share InfuSystem With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.